Cairo, Egypt, 4 February 2025: The Africa Centres for Disease Control and Prevention (Africa CDC) and African Union Development Agency – New Partnership for Africa’s Development (AUDA-NEPAD) are proud to announce the signing of a Memorandum of Understanding (MoU) among Africa’s WHO Maturity Level 3...
Pretoria - The leading agencies, the South African Health Products Regulatory Authority (SAHPRA) and the National Department of Health (NDoH) with identified key stakeholders for the National Action Plan (NAP) are in a three-day workshop this week (4-6 February 2025) to pilot the World Health...
Pretoria, 17 January 2025 – The South African Health Products Regulatory Authority (SAHPRA) has recommended that the product information of medroxyprogesterone acetate (MPA)-containing products be amended by updating the safety warnings to include the potential risk of meningioma. MPA is a synthetic oral and injectable form...
The South African Health Products Regulatory Authority (SAHPRA) wishes to inform stakeholders that the organisation's telephone system has been restored. SAHPRA apologises for any inconvenience this may have caused. ...
Please note that SAHPRA Head Office, including Cape Town and Durban Regional Offices will be unavilable today, 29 November 2024 due to the organisation's Annual General Meeting. If you require assistance, please use applicable contacts from Key Contacts: https://www.sahpra.org.za/key-contacts/ ...
SAHPRA offices will be closed for the festive season from 12:00 on Tuesday, 24 December 2024 and will re-open on Monday, 06 January 2025. Please note: Dates, placed within brackets for various email addresses, will guide stakeholders to the timeframes that emails will be processed. Dates, placed within...
Pretoria, 21 November 2024 – The South African Health Products Regulatory Authority (SAHPRA) is aware of a quality issue in a batch of YAZ Plus contraceptives (Batch No. WEW96J distributed on 09 and 24 November 2023) which has resulted in the incorrect arrangement of tablets...
Pretoria, 07 November 2024 – The South African Health Products Regulatory Authority (SAHPRA) encourages members of the public to always report any suspected side effects they may experience from taking medicines, vaccines and/or using medical devices, to help make medicines safer for everyone. While humanity...
The South African Health Products Regulatory Authority (SAHPRA) has published four (4) Expression of Interests (EOIs) since 2023, and these have all been closed. Updates on EOIs: Ref: SAHPRA69092024 - Pharmaceutical Evaluations Management EOI closed on Friday, 26 April 2024. Appointments were made. Ref: SAHPRA20862023 - The EOI...
Pretoria, 16 September 2024 –The South African Health Products Regulatory Authority (SAHPRA) is proud to announce that it has received its first clean audit outcome from the Auditor-General of South Africa (AGSA) for the 2023/2024 financial year, following on a record of consistent unqualified audit...
